Neuromedin N is a biologically active neuropeptide intricately linked to the neurotensin system within the body. It is a product of the same gene that gives rise to neurotensin, a peptide known for its roles in neurotransmission and the modulation of various physiological processes. Neuromedin N is synthesized as a part of a larger precursor protein that is subsequently cleaved to produce the active peptide. The distribution of neuromedin N is primarily in the central nervous system and the gastrointestinal tract, where it is involved in a multitude of regulatory functions. Despite being less studied than neurotensin, neuromedin N shares similar receptor targets and, therefore, may engage in comparable biological activities such as influencing thermoregulation, pain perception, and the dopaminergic system.
The expression of neuromedin N can potentially be influenced by various chemical activators that interact with cellular signaling pathways, leading to upregulation at the transcriptional level. Compounds such as forskolin, which increases intracellular cAMP, can promote the transcription of genes, and this mechanism might be applicable to the gene encoding neuromedin N. Similarly, agents like phorbol 12-myristate 13-acetate (PMA) that activate protein kinase C could trigger a cascade of intracellular events culminating in the upregulation of neuromedin N. Histone deacetylase inhibitors, for instance, sodium butyrate and trichostatin A, have the capacity to alter chromatin architecture, thereby potentially enhancing the expression of neuromedin N by making the gene more accessible for transcription. Other compounds such as retinoic acid and epidermal growth factor (EGF) bind to their respective receptors and may stimulate gene expression pathways that include neuromedin N. These activators operate through diverse mechanisms, indicating the complex regulation of neuromedin N and the intricate network of interactions that govern its synthesis. The dynamic nature of gene expression regulation in the body is exemplified by the potential influence of these chemical compounds on neuromedin N, highlighting the sophisticated orchestration of cellular function and protein production.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin can upregulate gene transcription by elevating intracellular cAMP, potentially leading to increased neuromedin N synthesis. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA might initiate a signaling cascade via protein kinase C activation, which could culminate in the upregulation of neuromedin N gene expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
By binding to its receptors, retinoic acid may initiate transcription of select genes, potentially stimulating the synthesis of neuromedin N. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride might stimulate neuromedin N expression by modulating GSK-3 activity, which is involved in neural gene expression pathways. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium butyrate, through its role as a histone deacetylase inhibitor, could induce neuromedin N expression by enhancing gene accessibility. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A may upregulate neuromedin N by inhibiting histone deacetylase, leading to changes in chromatin structure and gene expression. | ||||||
Kainic acid | 487-79-6 | sc-200454 sc-200454A sc-200454B sc-200454C sc-200454D | 5 mg 25 mg 100 mg 1 g 5 g | $85.00 $370.00 $1350.00 $7650.00 $24480.00 | 12 | |
Kainic acid, as an analog of glutamate, may stimulate neuromedin N expression by activating glutamate receptors and subsequent intracellular pathways. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
Dibutyryl-cAMP, a cAMP analog, might mimic the action of cAMP in neurons and upregulate neuromedin N expression through protein kinase A activation. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
Valproic acid can induce neuromedin N expression by inhibiting histone deacetylases, thus affecting gene expression patterns in neural tissue. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $62.00 $178.00 | 8 | |
β-Estradiol may upregulate neuromedin N expression via estrogen receptor-mediated transcriptional activation in neural cells. | ||||||